Classify

An experimental classification web service

Powered by the Classify Web Service.

Search Results

Search Criteria: FAST heading = COVID-19 (Disease)--Treatment
Displaying 1 to 25 of 147
Title & Author Format Holdings Editions From To
COVID-19 : current challenges and future perspectives by Kumar, Anoop
DDC/LCC
  1114 4 1901 2021
Fight back : beat the coronavirus by Crandall, Chauncey W.
DDC/LCC
  647 4 2020 2020
COVID-19 : diagnosis and management-part i by BHADADA, SANJAY KUMAR. KATARE. GARG, VARUN
DDC/LCC
  639 2 2021 2021
COVID-19 : the essentials of prevention and treatment by Qu, Jie-Ming
DDC/LCC/NLM
  526 10 1905 2021
The urgent need for a national plan to contain the coronavirus : hearing before the Select Subcommittee on the Coronavirus Crisis of the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, second session, July 31, 2020 by United States. Congress. House. Committee on Oversight and Reform. Select Subcommittee on the Coronavirus Crisis
LCC
  524 5 2020 2020
Coronavirus preparedness and response : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, second session, March 11-12, 2020 (a two day hearing) by United States. Congress. House. Committee on Oversight and Reform
LCC
  446 4 2020 2020
COVID-19 pandemic and the U.S. international response : hearing before the Committee on Foreign Relations, United States Senate, One Hundred Seventeenth Congress, first session, May 12, 2021 by United States. Congress. Senate. Committee on Foreign Relations
LCC
  432 2 2021 2021
Reviewing federal and state pandemic supply preparedness and response : joint hearing before the Subcommittee on Oversight, Management, and Accountability and the Subcommittee on Emergency Preparedness, Response, and Recovery, House of Representatives, One Hundred Sixteenth Congress, second session, July 14, 2020 by United States. Congress. House. Committee on Homeland Security. Subcommittee on Oversight, Management, and Accountability
LCC
  431 9 2021 2021
Repurposing therapeutic drugs for COVID-19 : research challenges and opportunities : hearing before the Subcommittee on Investigations and Oversight of the Committee on Science, Space, and Technology, House of Representatives, One Hundred Sixteenth Congress, second session, June 19, 2020 by United States. Congress. House. Committee on Science, Space, and Technology (2011- ). Subcommittee on Investigations and Oversight
LCC
  426 3 2021 2021
Hybrid hearing with Secretary of Health and Human Services Alex M. Azar II : hearing before the Select Subcommittee on the Coronavirus Crisis of the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, second session, October 2, 2020 by United States. Congress. House. Committee on Oversight and Reform. Select Subcommittee on the Coronavirus Crisis
LCC
  337 3 2020 2020
COVID-19: critical vaccine distribution, supply chain, program integrity, and other challenges require focused federal attention : report to congressional committees by United States. Government Accountability Office
LCC
  334 1 2021 2021
Drug safety: COVID-19 complicates already challenged FDA foreign inspection program : testimony before the Committee on Finance, U.S. Senate by United States. Government Accountability Office
LCC
  325 1 2020 2020
Drug safety: FDA's future inspection plans need to address issues presented by COVID-19 backlog : testimony before the Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies, Committee on Appropriations, House of Representatives by United States. Government Accountability Office
LCC
  310 1 2021 2021
National strategy for the COVID-19 response and pandemic preparedness : January 2021 by United States. President (2021- : Biden)
LCC
  302 4 2021 2021
Biomedical research : information on federal contributions to remdesivir: report to congressional committees by United States. Government Accountability Office
LCC
  286 1 2021 2021
Coronavirus disease 2019 (COVID 19) : epidemiology, pathogenesis, diagnosis, and therapeutics by Saxena, Shailendra K., 1950-
DDC/LCC/NLM
  275 12 2020 2020
Moving beyond the coronavirus crisis : the Biden administration's progress in combating the pandemic and plan for the next phase : hearing before the Select Subcommittee on the Coronavirus Crisis of the Committee on Oversight and Reform, House of Representatives, One Hundred Seventeenth Congress, second session, March 30, 2022 by United States. Congress. House. Committee on Oversight and Reform. Select Subcommittee on the Coronavirus Crisis
LCC
  273 2 2022 2022
Neurological care and the COVID-19 pandemic by Ramadan, Ahmad Riad
DDC/LCC/NLM
  267 7 2021 2021
National COVID-19 preparedness plan : March 2022 by United States. President (2021- : Biden)
LCC
  254 3 2022 2022
Novel Coronavirus 2019 : In-silico Vaccine Design and Drug Discovery by Kumar, Amit
DDC/LCC/NLM
  250 10 2020 2020
Frontline. America's medical supply crisis
LCC
  230 2 2020 2020
COVID-19: federal efforts accelerate vaccine and therapeutic development, but tranparency needed on emergency use authorizations : report to congressional addressees by United States. Government Accountability Office
LCC
  226 1 2020 2020
Covid-19 airway management and ventilation strategy for critically ill older patients by Esquinas, Antonio M. [Editor]
DDC/LCC/NLM
  224 6 2020 2020
COVID-19 contracting : observations on federal contracting in response to the pandemic : report to congressional committees by United States. Government Accountability Office
LCC
  211 1 2020 2020
The clinical diagnosis and treatment for new coronavirus pneumonia by Cheng, Fanjun [Editor]
DDC/LCC/NLM
  203 4 2020 2020
Displaying 1 to 25 of 147
.